Staff Profiles

Prof. James Aggrey Oloo

oloo

Contact details
School of Public Health Biomedical Sciences,
Department of Public Health,
P.O. BOX 190- 50100
Kakamega, Kenya
Office No: ABA 111
Kakamega- Webuye Road
Email: This email address is being protected from spambots. You need JavaScript enabled to view it..
ResearcherID: CAF-3948-2022
ORCID: https://orcid.org/0000-0001-7495-1827

Google Scholar:  en&authuser=1

Prof. James Aggrey Oloo.

Professor James Aggrey Oloo is a Professor of Medicine at Masinde Muliro University of Science and Technology. He teaches undergraduate and graduate students in the School of Medicine and School of Public Health Biomedical Sciences and Technology. He is an External Examiner for Medicine and Public Health students in Kenya and East Africa
His areas of academic interest and research are in the fields of Infectious diseases, Malariology, Haemoglobinopathies (Sickle Cell Anaemia), epidemiologic studies, and health systems and policy
He holds a Bachelor of Medicine and Bachelor of Surgery (MB ChB) degree from the University of Nairobi (1977), Masters of Medicine (M Med Internal Medicine) degree from the University of Nairobi (1983), Diploma in Tropical Medicine and Hygiene from the University of Liverpool, England (1986), Post Graduate Diploma in Clinical Epidemiology from the University of Newcastle, NSW, Australia(1997). He is a Fellow of the College of Physicians of East Central and Southern Africa, FCP (ECSA) since 2016.
He has supervised 7 PhDs and 13 Masters.


His professional Fellowships and Accreditations Certifications are;

  1.  CIBA – Geigy Fellowship on Tropical Medicine (1986);
  2.  WHO/TDR Fellowship on Clinical Epidemiology(1987);
  3. KenyaAssociation of Physicians (KAP);
  4. Kenya Medical Association (KMA);
  5. Accreditation- Kenya Medical Practitioners and Dentists Board Licensure Nr 1468
  6. College of Physicians for East Central and Southern Africa.

Some of his Major publications:

  1. S. Abebe,L. Siktberg, W. Mucherah,J. A. Oloo, E. O. Khasakhala, J. Muliira,J. Kandiah, G. Hall,  A. Kroot.  Evaluation of a pilot interprofessional train-the-trainer workshop to enhance sickle cell anemia community education in Kenya. Published on 27th October 2023 in East African Medical Journal.  https://www.ajol.info/index.php/eamj/article/view/258009
  2. W. Mucherah, S.Y. Abebe, J. Kandiah, L. Siktberg, J.A. Oloo, R.N. Thomas. An educational intervention to increase awareness and knowledge of sickle cell anaemia among adolescent school children in western Kenya. https://www.ajol.info/index.php/eamj/article/view/234651
  3.  Catherine V. Donovan,1,* Peter McElroy,2 Linda Adair,1 Brian W. Pence, Aggrey James Oloo, Altaf Lal, Peter Bloland, Bernard Nahlen, Jonathan J. Juliano, and Steven Meshnick. Association of Malnutrition with Subsequent Malaria Parasitemia among Children Younger than Three years in Kenya: A Secondary Data Analysis of the Asembo Bay Cohort Study.Am J Trop Med Hyg. 2021 Jan; 104(1): 243–254.Published online 2020 Nov 16. doi: https://doi.org/10.4269/ajtmh.20-0002

  4. Morris Shisanya,John Arudo,James Aggrey Oloo, Everlyne Nyanchera Morema.The impact of Co-morbidity and Treatment Characteristics on Adherence to Tuberculosis Treatment in Kisumu East Subcounty, Kenya.October 2017. DOI: https://doi.org/10.9790/1959-0605078791.
  5. James Aggrey Oloo, Charles Chunge, Maragraet Oloo, Maximila Wanzala, Consolata Oloo Ngala. Sickle Cell Anaemia - the burden of balanced polymorphism. October 2016 https://www.researchgate.net/publication/307977874_Sickle_Cell_Anaemia_-_the_burden_of_balanced_polymorphism
  6. Francesco Checchi, Paul Roddy, Sarian Kamara, Arthur Williams, Guy Morineau, Abdul Rahman Wurie, Bona Hora, Nadine de Lamotte, Tim Baerwaldt, Annette Heinzelmann, Alison Danks, Loretxu Pinoges, Aggrey Oloo, Rémy Durand, Lisa Ranford-Cartwright, Martin Smet, Sierra Leone Antimalarial Efficacy Study Collaboration.Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.DOI: https://doi.org/10.1111/j.1365-3156.2004.01367.x.
  7. Edward Mberu Kamau, James Aggrey Oloo. Developing Traditional Medicine to Roll Back Malaria in Africa. January 2006 https://afrolib.afro.who.int/documents/2006/eng/rollbackmalaria.pdf
  8. A Moore 1, G Herrera, J Nyamongo, E Lackritz, T Granade, B Nahlen, A Oloo, G Opondo, R Muga, R Janssen.Estimated risk of HIV transmission by blood transfusion in Kenya. DOI: https://doi.org/10.1016/S0140-6736(01)05783-X
  9. C O Obonyo, E W Steyerberg, A J Oloo, J D Habbema.Blood transfusions for severe malaria-related anemia in Africa: a decision analysis. Am J Trop Med Hyg. 1998 Nov. DOI: https://doi.org/10.4269/ajtmh.1998.59.808.
  10. J A Sherwood 1, R S Copeland, K A Taylor, K Abok, A J Oloo, J B Were, G T Strickland, D M Gordon, W R Ballou, J D Bales Jr, R A Wirtz, J Wittes, M Gross, J U Que, S J Cryz, C N Oster, C R Roberts, J C Sadoff.Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya. Clinical Trial Vaccine. 1996 Jun. DOI: https://doi.org/10.1016/0264-410x(95)00221-l.
  11. C Beadle , P D McElroy, C N Oster, J C Beier, A J Oloo, F K Onyango, D K Chumo, J D Bales, J A Sherwood, S L Hoffman.Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design. J Infect Dis.1995 Oct. DOI: https://doi.org/10.1093/infdis/172.4.1047. 
  12. S L Andersen 1, A J Oloo, D M Gordon, O B Ragama, G M Aleman, J D Berman, D B Tang, M W Dunne, G D Shanks. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clinical Trial Clin Infect Dis. 1998 Jan DOI: https://doi.org/10.1086/516281.
  13. W R Weiss 1, A J Oloo, A Johnson, D Koech, S L Hoffman. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.Clinical Trial J Infect Dis. 1995 Jun; DOI: https://doi.org/10.1093/infdis/171.6.1569.
  14. G D Shanks 1, A J Oloo, G M Aleman, C Ohrt, F W Klotz, D Braitman, J Horton, R Brueckner. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.Clinical Trial Clin Infect Dis.2001 Dec 15. DOI: https://doi.org/10.1086/324081.
  15. Adjuik, M; Agnamey, P; Babiker, A; Baptista, J; Borrmann, S; Brasseur, P; Carnevale, P; Cisse, M; Collins, R; D'Alessandro, U; Day, N; de Boom, W; Doherty, T; Dorsey, G; Garner, P; Gikunda, S; Gil, V; Greenwood, B; Guthmann, JP; Henry, MC; Kamya, MR; Kremsner, PG; Konate, E; Krishna, S; Lalloo, D; Lange, P; Loolpapit, M; Malenga, G; Marquino, W; Marsh, K; Milligan, P; Molyneux, M; Mugittu, K; Niangue, J; Nosten, F; Ntoumi, F; Obonyo, C; Ochieng, F; Olliaro, P; Oloo, AJ; Osorio, L; Pinoges, L; Priotto, G; Rosenthal, PJ; Ruebush, T; Simpson, J; Sirima, S; Some, E; Taylor, W; ter Kuile, F; Tiono, A; von Seidlein, L; Watkins, B; White, N. Artesunate combinations for treatment of malaria: meta-analysis.Published in The Lancet on January 03, 2004.DOI: https://doi.org/10.1016/S0140-6736(03)15162-8
  16. RalphR. Frerichs, J.E. Garay, B.L. Nahlen, M.M.ter Kuile, J.M. Richters,A. Oloo, P.A. Phillips-Howard, John Green, John KentishThe right not to know HIV-test results.Published:June 10, 1995DOI: https://doi.org/10.1016/S0140-6736(95)91064-6.
  17. Parise, ME; Ayisi, JG; Nahlen, BL; Schultz, LJ; Roberts, JM; Misore, A; Muga, R; Oloo, AJ; Steketee, RW. Efficacy of sulfadoxlne-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Published in The American Journal of Tropical Medicine and Hygiene on November 01, 1998. Published:Nov 1998 in The American Journal of Tropical Medicine and Hygiene DOI: https://doi.org/10.4269/AJTMH.1998.59.813

 

View full CV here:

 

 

Live Search

Search